Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$0.00 – $0.02
2% from low
Exchange
OTC Link
CS
P/S (TTM)
0.0
SYROS PHARMACEUTICALS INC
No one on the platform currently holds SYRS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 96,042 | $22.1K |
| Execution date | Ratio |
|---|---|
| 2022-09-19 | 1-for-10reverse |
No one on the platform has traded SYRS yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2M | -66.7% | $-0.60 | $-0.60–$-0.60 | — | 1 |
| 2027 | $2M | +0.0% | $-0.65 | $-0.65–$-0.65 | — | 1 |
| 2028 | $2M | +0.0% | $-0.65 | $-0.65–$-0.65 | — | 1 |
| 2029 | $32M | +1811.9% | $-0.70 | $-0.70–$-0.70 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-03-26 | $-0.70 | $-1.19 | -70.0% |
| 2024-10-31 | $-0.76 | $-0.16 | +78.9% |
| 2024-07-31 | $-0.79 | $-0.70 | +11.4% |
| 2024-05-14 | $-0.89 | $-0.10 | +88.8% |
| 2024-03-27 | $-1.14 | $-2.18 | -90.6% |
| 2023-11-14 | $-1.12 | $-1.35 | -20.5% |
| 2023-08-08 | $-1.11 | $-1.30 | -17.1% |
| 2023-05-10 | $-1.12 |
| $-0.85 |
| +24.1% |
| +0.00% |
| $274265 |
| — |
| NUVOHoldco Nuvo Group D.G Ltd. Ordinary Shares | $0.17 | +100.00% | $6M | — |
| PPBTPurple Biotech Ltd. | $1.72 | -2.27% | $237504 | — |
Source: Financial Modeling Prep · peers by sector/industry
Fundamental analysis of $SYRS (Syros Pharmaceuticals, Inc.) based on financial data and reported results. #SYRS #Syros
View on StockTwits ↗@cb5000calls @Love_To_Learn CB..I am in SLS because of your cross posts to $SYRS after it went caput…Bad prior mistakes, but patience is a strength of mine. Send me a non-profit of your choice and I’ll make a donation no matter if sls is successful or not. Comment here or follow and DM me. Your choice. Get better. 💪✌️
View on StockTwits ↗$SYRS I thought this was delisted and BK. What’s this nonsense.
View on StockTwits ↗$BTAI POS stock. Prob gonna add to the family and be the same as $SYRS $PTN $OPT . Check these twits out at their board
View on StockTwits ↗@BayAreaBiotech thats where the divergance are. There are so many companies examples where insiders buy near to catalyst. I.e clinical trials results and flop. $syrs was one of them. Insiders bought before catalyst. And now $rfl too. Go see their stocktwits posts as well. Be it flunk, flop or not. Insiders do buy before clinical trials outcome, i.e catalyst announcement
View on StockTwits ↗$SYRS why this is still trading? Feb 28, 2025 4:05 PM Eastern Standard Time Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration delisting and deregistration of its common stock on or about March 10, 2025 and the delisting is expected to become effective on or about March 20, 2025.
View on StockTwits ↗$SYRS Ehi, take a look at RCIT today and see what a raging stock in OTC can do!!! +29,674,281.25%
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.